Pharma Holdings As
In a world with an increasing number of resistant and difficult-to-treat microbes, Pharma Holdings has set off to develop new drugs that are rapid acting and with a low propensity towards resistance development. Our new generation cationic peptide is the result of world-class research in the field of lytic peptides. Further, our compound LTX-109 is derived from a naturally occurring peptide which, together with the low drive towards resistance development, ensures a sustainable way of fighting off infections currently threatening the global health.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Pharma Holdings As
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- NH
Niklas Hammarstedt
Å Ö · Other
EmailPhone
Showing 1 of 3 verified contacts
Top roles at Pharma Holdings As
3 distinct titles indexed · top 3 shown.
- 1ceo
- 1cfo
- 1å ö
Sign up to unlock all 3 contacts at Pharma Holdings As
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Pharma Holdings As
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.